Outcomes of COVID-19 in people with rheumatic and musculoskeletal disease in Ireland over the first 2 years of the pandemic.

Richard P ConwayElena NikiphorouChristiana A DemetriouCandice LowKelly LeamyJohn G RyanRonan KavanaghAlexander D FraserJohn J CareyPaul O'ConnellRachael M FloodRonan H MullanDavid J KaneFrances StaffordPhilip C RobinsonJean W LiewRebecca GraingerGeraldine M McCarthynull null

Published in: Irish journal of medical science (2023)

Hospitalisation or death were more frequently experienced by RMD patients with increasing age, certain comorbidities including potentially modifiable ones, and certain medications and diagnoses amongst other factors. These are important 'indicators' that can help risk-stratify and inform the management of RMD patients.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
rheumatoid arthritis
peritoneal dialysis
metabolic syndrome
patient reported outcomes
type diabetes
respiratory syndrome coronavirus
skeletal muscle
insulin resistance
weight loss